Essity


A well-balanced health and hygiene proposition

08/01/19 -"Recommendation and upside We are initiating coverage of Essity (market cap: SEK152bn/€15bn and free float: 91%) with an ‘Add’ recommendation and a target price of SEK229 per share (5.5% upside). Our ..."

Pages
54
Language
English
Published on
08/01/19
You may also be interested by these reports :
22/03/24
We have adopted a more positive stance to reflect the fact that Beiersdorf has undergone a rejuvenation and is better positioned for growth with all ...

21/03/24
Reckitt’s share price has dropped by nearly 18% since a jury in Illinois asked the firm to pay $60m to a mother who lost her pre-term baby to NEC ...

19/03/24
We welcome this major shift by Unilever’s new management. This separation will allow Unilever to withdraw from the segment with the lowest margin and ...

05/03/24
Reckitt reported softer than expected Q4/FY23 numbers. Q4 growth in Hygiene was more than offset by declines in other segments. More importantly, an ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO